Published Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Member News
Copy The Link to the  Article
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development
The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Copy The Link to the  Article

Related or similar articles

View more News
October 9, 2024

Explore Labshares' Latest High-Tech Equipment Advancements

Labshares News
April 25, 2024

Laboratory Space for Emerging Biotechs:  Best Practices and Tips from Labshares 

Labshares News
October 31, 2018

Labshares Newton Launches Near Capacity and Announces Expansion Plans

Labshares Newton, an office and laboratory incubator for emerging biotechnology and life science companies, announced the launch of its first location in Newton.
Press Releases